[Etanercept].
作者信息
Mühlhäuser U, Münzel F, Eschenhagen T
机构信息
Institut für Experimentelle und Klinische Pharmakologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg.
出版信息
Dtsch Med Wochenschr. 2003 Aug 22;128(34-35):1775-8. doi: 10.1055/s-2003-41702.
PMID:12934172
Abstract
摘要
相似文献
1
[Etanercept].[依那西普]
Dtsch Med Wochenschr. 2003 Aug 22;128(34-35):1775-8. doi: 10.1055/s-2003-41702.
2
[Therapy of psoriasis vulgaris and psoriatic arthritis with etanercept].用依那西普治疗寻常型银屑病和银屑病关节炎
J Dtsch Dermatol Ges. 2005 Jun;3(6):470-2. doi: 10.1111/j.1610-0387.2005.04541.x.
3
Etanercept (Enbrel) -- an update.依那西普（恩利）——最新情况
Skin Therapy Lett. 2004;9(10):1-4, 9.
4
[TNF-alpha inhibitors].[肿瘤坏死因子-α抑制剂]
Rev Prat. 2003 Nov 30;53(18):1989-90.
5
Treatment of rheumatoid arthritis with etanercept.依那西普治疗类风湿关节炎
Rheum Dis Clin North Am. 2004 May;30(2):311-28, vi-vii. doi: 10.1016/j.rdc.2004.01.004.
6
Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis.类风湿关节炎和青少年慢性关节炎中的抗肿瘤坏死因子α转换
Arthritis Rheum. 2004 Apr 15;51(2):301-2. doi: 10.1002/art.20242.
7
Clinical pharmacokinetics of etanercept: a fully humanized soluble recombinant tumor necrosis factor receptor fusion protein.依那西普的临床药代动力学：一种完全人源化的可溶性重组肿瘤坏死因子受体融合蛋白。
J Clin Pharmacol. 2005 May;45(5):490-7. doi: 10.1177/0091270004273321.
8
Post-approval trials of new medicines: widening use or deepening knowledge? Analysis of 10 years of etanercept.新药品的上市后试验：扩大使用还是加深认识？依那西普十年分析。
Scand J Rheumatol. 2011 May;40(3):183-91. doi: 10.3109/03009742.2010.509102. Epub 2010 Sep 21.
9
Etanercept therapy in children with juvenile rheumatoid arthritis.依那西普治疗幼年类风湿关节炎患儿
J Microbiol Immunol Infect. 2005 Dec;38(6):444-6.
10
Taiwan experience with etanercept in juvenile rheumatoid arthritis.台湾使用依那西普治疗青少年类风湿关节炎的经验。
J Microbiol Immunol Infect. 2005 Dec;38(6):451-4.
Zotero 插件